Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Other Non-Current Liabilities: 2015-2020

Historic Other Non-Current Liabilities for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Dec 2020 value amounting to $1,000.

  • Syndax Pharmaceuticals' Other Non-Current Liabilities fell 80.00% to $1,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $1,000, marking a year-over-year decrease of 80.00%. This contributed to the annual value of $1,000 for FY2020, which is 80.00% down from last year.
  • Syndax Pharmaceuticals' Other Non-Current Liabilities amounted to $1,000 in FY2020, which was down 80.00% from $5,000 recorded in FY2019.
  • Syndax Pharmaceuticals' Other Non-Current Liabilities' 5-year high stood at $310,000 during FY2017, with a 5-year trough of $1,000 in FY2020.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $5,000 (2019), whereas its average is $47,333.
  • In the last 5 years, Syndax Pharmaceuticals' Other Non-Current Liabilities increased by 7.64% in 2017 and then crashed by 96.32% in 2019.
  • Over the past 5 years, Syndax Pharmaceuticals' Other Non-Current Liabilities (Yearly) stood at $288,000 in 2016, then rose by 7.64% to $310,000 in 2017, then plummeted by 56.13% to $136,000 in 2018, then tumbled by 96.32% to $5,000 in 2019, then tumbled by 80.00% to $1,000 in 2020.